Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $4.1B |
| Sales growthchange from the year before | +0.7% |
| Gross marginshare of sales left after the direct cost of what it sells | 30.2% |
| Operating marginshare of sales left after running the business | 10.1% |
| Net marginshare of sales kept as profit | 8.5% |
| Free-cash-flow marginspare cash generated per $100 of sales | 7.6% |
| Return on invested capitalprofit made on each $100 put into the business | 13.5% |
| Return on equityprofit vs. shareholders' accounting value | 21.5% |
| Debt / equitydebt vs. shareholders' accounting value | 0.49 |
| Change in share countnegative = the company is buying back its shares | -1.6% |
1 insider bought $101K; 1 insider sold $396K on the open market.
| Freye Theodor WernerDirector | SoldJul 27 | 800 shat $495.00 · $396K |
| Schwietz John LExecutive VP and CFO | BoughtJul 23 | 208 shat $486.15 · $101K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy